Statins and safety: Overview for patient care
Hypercholesterolemia is one of the major modifiable risk factors for coronary heart disease. To reach target cholesterol levels, many patients require a combination of lifestyle changes and lipid-lowering therapy.1
Over the last decade clinical trials have demonstrated that low-density lipoprotein cholesterol (LDL-C) reduction with statin therapy decreases the risk of cardiac events substantially in patients with coronary heart disease, including those with normal cholesterol levels,2,3
and in healthy high-risk patients irrespective of serum cholesterol level.4,5
References are listed at the end of the Data Alert.
Download 04DA_SAFETY.ppt (6 slides - 1.3MB)